Efficacy of chemotherapy in limited-disease small-cell lung cancer

By Kenmotsu Hirotsugu  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 483-492

Future Medicine

Access to resources Recommend Favorite

Mid-course thoracic radiotherapy with cisplatin-etoposide chemotherapy in limited-stage small-cell lung cancer

By Akyurek Serap   Onal Cem   Cagar Aysun   Hicsonmez Ayse   Andrieu Meltem   Kurtman Cengiz  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 499-505

Humana Press, Inc

Access to resources Recommend Favorite

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

By Oka M.   Fukuda M.   Kuba M.   Ichiki M.   Rikimaru T.   Soda H.   Tsurutani J.   Nakamura Y.   Kawabata S.   Nakatomi K.   Narasaki F.   Nagashima S.   Takatani H.   Fukuda M.   Kinoshita A.   Kohno S.  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 1998-2004

Elsevier

Access to resources Recommend Favorite

Early Alternating Chemotherapy and Radiotherapy Schedule in Limited Disease Stage Small Cell Lung Cancer

By Purohit A.   Charloux A.   Jung G.-M.   Dietemann A.   Fraisse P.   Schumacher C.   Quoix E.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1434-1436

Elsevier

Access to resources Recommend Favorite

Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.

By Hallqvist Andreas   Rylander Hillevi   Björk-Eriksson Thomas   Nyman Jan  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 969-974

Informa Healthcare

Access to resources Recommend Favorite